Meta closed October 26, 2026 at $630.56, down 1.88% from $642.62 on 30.80 million shares, equal to 1.59x the 19.40 million 20-day average, delivering a decisive close below both the October 23 low of $633.27 and the at $644.49 and thereby triggering the invalidation signal flagged in the prior run. The stock now sits 2.16% below the , 6.79% below the at $676.47 and 11.61% below the at $713.40, with the bearish histogram widening for a sixth session to -15.55 ( -7.06 versus signal 8.49), down to 33.67 without a positive divergence, and printing a fresh window low of -117.80 million, a further 30.80 million shares of distribution in a single session. The relative weakness is telling, because on October 26 the S&P 500 rose 0.70% to 7,676.77, the Nasdaq rose 0.82% and the fell 5.45% to 18.39, yet Meta fell 1.88% on expanding volume, which is stock-specific selling rather than beta. The franchise itself still compounds, with 26.1% revenue growth, an 81.03% gross margin, a 35.41% operating margin, a 48.09% margin, a 32.26% and $133.09 billion of operating cash flow, but cash conversion deteriorated again, with trailing free cash flow down to $16.85 billion, only 12.7% of operating cash flow and a 1.05% free-cash-flow yield. The Q3 2026 miss of 29.9% ($3.83 versus $5.46478) remains the dominant fundamental event, the second consecutive shortfall after -14.4% in June, and FY2026 has been cut again to $29.20173 from $30.46424 seven days ago (-4.1%) and $33.04684 ninety days ago (-11.6%). The one constructive thread is the out year: FY2027 edged up to $33.97029 from $33.82523 a week ago and the current-quarter estimate rose to $8.33709 from $8.27679, so the near-term bar is being reset lower while the out-year estimate holds. Valuation has de-rated with the price to 21.51x trailing, 17.97x forward, 14.42x , 6.65x sales and 5.92x book, with a of 0.85 that is far more credible than the prior run's 0.08 artifact but that rests on an implied roughly 21% growth rate which two consecutive misses have made less certain. Sell-side posture remains constructive, with 9 Strong Buy, 46 Buy, 6 Hold and 1 Sell across 62 ratings, zero upgrades or downgrades in 90 days, and post-print target raises from UBS to $892, Citigroup to $905, DA Davidson to $800, BMO to $685 and Evercore to $870, leaving a $845.50 mean target that implies 34.1% upside, although the $629.06 low target has now converged to the current price and the $420.94 high-to-low spread equals 66.8% of the share price. The macro backdrop is Neutral at 18.39 and a 10-year Treasury yield of 4.986%, marginally friendlier than the prior session, but a 1.185 beta and 38.12% realized volatility mean Meta amplifies any risk-off move. With no company catalyst before the January 27, 2027 report, 92 days away, the key risk is that AI infrastructure spending keeps converting 26% revenue growth into falling and worsening free cash flow while both the multiple and the trend remain broken.
Decision
Live price
$625.18
Recommendation score
40%
40%
Confidence
68%
68%
Outlook by horizon
1M
SELL
Near
6M
HOLD
Mid
1Y
BUY
Long
Primary catalyst
The Q3 2026 earnings miss remains by far the most market-moving item, with of $3.83 versus a $5.46478 consensus, a 29.9% shortfall that drove a 6.99% decline on 40.57 million shares and has now extended into a decisive close below the October 23 low of $633.27 at $630.56 on 1.59x average volume. The follow-through in FY2026 estimate revisions and the durability of the $600-$630 support band will determine whether this is a one-quarter reset or a broader earnings-quality de-rating, with no offsetting company catalyst scheduled before the January 27, 2027 report.
Cap at one-third to one-half of normal size and do not add at current levels. Supporting caution: the October 23 low of $633.27 was decisively broken on October 26 on 1.59x average volume, price is 2.16% below the at $644.49, is -7.06 with the histogram widening to -15.55, printed a new window low at -117.80 million, FY2026 is down 4.1% in seven days, 20-day realized volatility is 38.12% and is 4.07% of price, with no company catalyst until January 27, 2027. Scale to a full position only after either a close back above the at $644.49 on improving volume or a stabilization in FY2026 revisions.
Thesis Snapshot
Why It Works
The strongest argument for owning Meta here is that the core franchise still compounds faster than almost any business of this size while costs remain software-like: revenue is growing 26.1% year over year at an 81.03% gross margin, a 35.41% operating margin, a 48.09% margin and a 32.26% , producing $133.09 billion of operating cash flow against net debt of just $32.39 billion, or 2.02% of market capitalization. After the decline to $630.56 the stock trades at 17.97x forward earnings, 14.42x , 6.65x sales and a 0.85 , roughly 19.1% below its 52-week high and at the 42nd percentile of the annual range, and the $629.06 low analyst target has converged to the price, implying the most bearish sell-side view now sees essentially no downside. Muse reportedly reached the top of both major app stores with millions of users, the Enterprise Platform launch knocked Atlassian down 4.6% intraday, and the transaction take-rate model plus hardware extensions through glasses and the Muse Charm give Meta multiple new monetization surfaces not yet reflected in consensus numbers. The sell-side has kept raising targets after the print, with UBS at $892, Citigroup at $905, DA Davidson at $800 and Evercore at $870, leaving a $845.50 mean target that still implies 34.1% upside, and FY2027 has actually risen to $33.97029 from $33.82523 a week ago while the current-quarter estimate ticked up to $8.33709. The one arguable technical positive is that the break is only 2.16% deep and at 33.67 is approaching oversold, so a violent snap-back rally toward $676-$713 is possible if FY2026 revisions stop falling.
What Breaks It
The strongest argument against owning Meta now is that the invalidation signal has already fired: the October 26 close at $630.56 is below the October 23 low of $633.27 on 30.80 million shares, 1.59x the 20-day average, and 2.16% below the at $644.49, meaning the prior run's entire accumulation thesis spanning the $610-$640 entry zone is now underwater. This is not a light-volume false break; printed a fresh window low at -117.80 million, crossed to -7.06 with the histogram widening for a sixth session to -15.55, at 33.67 is making lower lows with no positive divergence, and the stock fell 1.88% on a day the S&P 500 rose 0.70% and the fell 5.45%, which is textbook stock-specific distribution. The fundamental record is equally uncomfortable: missed by -14.4% in Q2 2026 and -29.9% in Q3 2026, FY2026 is down 4.1% in seven days and 11.6% in ninety days, next-quarter is down 8.7% in ninety days, and free cash flow fell to $16.85 billion, only 12.7% of operating cash flow and a 1.05% yield, showing 26.1% revenue growth is being absorbed by AI infrastructure and depreciation. Analyst dispersion of $629.06 to $1,050, a $420.94 spread equal to 66.8% of the share price, signals genuine disagreement rather than confidence, and short interest of just 1.52% of float means there is no squeeze fuel to cushion a disappointing January print. The main risk is sequential: a gap-fill toward the $600 psychological level and then the $520.26 52-week low is a realistic path if $627.82 fails.
The accumulation thesis has already been partially invalidated by the October 26 close at $630.56 below the October 23 low of $633.27 on 1.59x average volume; a further decisive daily close below $627.82, the October 26 low, would confirm that the $600-$630 support band is failing and open the $600 psychological level and then the $520.26 52-week low. On the fundamental side, another cut to FY2026 below $29.20173 combined with capex guidance above the previously recorded $135-$145 billion would confirm that AI spending is overwhelming near-term earnings power even if the chart repairs.
Earnings-quality deterioration: Q3 2026 missed by 29.9% ($3.83 versus $5.46478) after a -14.4% miss in June 2026, and FY2026 has been cut 4.1% in the last seven days to $29.20173 from $30.46424 and 11.6% over ninety days from $33.04684, leaving management credibility impaired heading into the January 27, 2027 print.
Technical breakdown risk: price closed at $630.56, 2.16% below the at $644.49, after breaking below the at $676.47 and the at $713.40, with at -7.06, histogram at -15.55, at 33.67 and at a new window low of -117.80 million; a close below $627.82 targets $620 and then $600.
Capex and cash-conversion risk: free cash flow fell to $16.85 billion against $133.09 billion of operating cash flow, only 12.7% conversion with a 1.05% free-cash-flow yield, and the prior FY2026 capex guidance of $135-$145 billion is unverified in this bundle, leaving depreciation and operating costs capable of absorbing 26.1% revenue growth.
Macro and multiple risk: the 10-year Treasury yield at 4.986%, beta of 1.185, 38.12% realized volatility and at 4.07% of price all amplify drawdowns on a name trading at 17.97x forward earnings, even with the easing to 18.39.
Monetization and trust risk: Muse accesses inboxes, calendars, financial information and purchase decisions, and William Blair commentary highlights privacy and security as a key competitive differentiator, yet the bundle contains no evidence of paid-conversion scale or quantified enterprise revenue, leaving the 6.65x sales multiple dependent on unproven monetization.
Data-quality and consensus risk: Bollinger Band fields are null, the price-target analyst count is null, the two insider Form-4 rows have garbled date fields and blank transaction types, and analyst targets span $629.06 to $1,050, so several bundle fields should be treated as directional rather than precise.
Watch Next
Next earnings: Jan 27, 2027
The Q3 2026 earnings miss remains by far the most market-moving item, with of $3.83 versus a $5.46478 consensus, a 29.9% shortfall that drove a 6.99% decline on 40.57 million shares and has now extended into a decisive close below the October 23 low of $633.27 at $630.56 on 1.59x average volume. The follow-through in FY2026 estimate revisions and the durability of the $600-$630 support band will determine whether this is a one-quarter reset or a broader earnings-quality de-rating, with no offsetting company catalyst scheduled before the January 27, 2027 report.
Signal Dashboard
Decision inputs
6 signals
Fundamental
34.1%
Upside to analyst mean target
At $630.56 Meta trades at 21.51x trailing earnings, 17.97x forward, 14.42x , 6.65x sales and 5.92x book, all lower than the prior run (21.92x trailing, 18.47x forward, 14.76x , 6.78x sales, 6.02x book), but again the improvement is entirely price-driven after the further 1.88% decline rather than estimate-driven. The of 0.85 is far more usable than the prior run's 0.08 artifact, which was computed off a low-base 264.8% earnings-growth figure; if the implied roughly 21% growth rate holds, a sub-1.0 would make Meta cheap relative to growth, but two consecutive misses (-14.4% in June 2026 and -29.9% in September 2026) and an 11.6% ninety-day cut to FY2026 argue the growth denominator is still too high. The honest anchor is a 17.97x forward multiple on FY2026 of $29.20173, which has fallen 4.1% in seven days, against 26.1% revenue growth, an 81.03% gross margin and a 1.05% free-cash-flow yield. The market is paying roughly 14.4x for a 48.09% -margin business, which is not demanding in absolute terms, but 6.65x sales already discounts Muse and Enterprise Platform monetization that has not appeared in reported revenue. Enterprise value of $1.675 trillion is only 1.04x market capitalization, so the valuation rests on operating earnings power rather than leverage. The stock is 19.14% below its 52-week high of $779.82 and 21.20% above its $520.26 low, at the 42.49 percentile of the annual range.
Technical
Bearish
Trend quality
The $630.56 close is 11.61% below the at $713.40, 6.79% below the at $676.47, and 2.16% below the at $644.49, the second consecutive close beneath the long-term trend line after the October 23 break and now a decisive one. still sits $31.98 above , so the golden cross formed in late September remains technically intact but is narrowing quickly. The October 22 session gapped down from the prior $697.52 close and closed near its low at $648.85; October 23 opened at $638.18, printed a $633.27 low and closed at $642.62, failing to reclaim the ; October 26 then opened at $637.89, printed a $627.82 low and closed at $630.56, cementing a close below the October 23 low on heavy volume. The lower-high sequence at $779.82 (September 24), $771.27 (October 13), $743.97 (October 15), $713.22 (October 21), $648.04 (October 23) and now $647.69 (October 26) is firmly intact. The primary and intermediate uptrends are broken and the stock is in a confirmed downtrend testing the $600-$630 area.
Earnings
92d
Deteriorating
The September 30, 2026 quarter delivered of $3.83 against a $5.46478 consensus, a 29.9% miss and the second consecutive shortfall after a -14.4% miss in June 2026, and the stock reacted by falling 6.99% on October 22 to $648.85 on 40.57 million shares (about 2.1x the then 19.25 million 20-day average), eased another 0.96% to $642.62 on October 23, and then broke down a further 1.88% to $630.56 on October 26 on 30.80 million shares (1.59x the current 19.40 million average). The bundle contains no revenue line, margin detail or management guidance for the quarter, so the shortfall cannot be decomposed into one-time items versus operating deterioration, and the recent-earnings-date list covering 2020-2022 is stale.
News
Mixed-Bearish
Headline tone
The Q3 2026 earnings miss remains by far the most market-moving item, with of $3.83 versus a $5.46478 consensus, a 29.9% shortfall that drove a 6.99% decline on 40.57 million shares and has now extended into a decisive close below the October 23 low of $633.27 at $630.56 on 1.59x average volume. The follow-through in FY2026 estimate revisions and the durability of the $600-$630 support band will determine whether this is a one-quarter reset or a broader earnings-quality de-rating, with no offsetting company catalyst scheduled before the January 27, 2027 report.
Macro
Neutral
4.99% 10Y / 18.4 VIX
at 18.39 keeps this in Neutral rather than Risk-Off and equities rose on October 26, but a 10-year Treasury yield at 4.986% plus a 1.185 beta and 38.12% realized volatility mean Meta's 17.97x forward multiple remains directly exposed to long-yield pressure and, more acutely, to its own estimate resets.
Stability
High-Beta Growth
Core Growth
Meta remains a high-quality advertising and AI platform: revenue is growing 26.1% year over year at an 81.03% gross margin, a 35.41% operating margin, a 48.09% margin and a 32.26% , with $133.09 billion of operating cash flow against net debt of $32.39 billion that equals only 2.02% of the $1.606 trillion market cap. That quality is offset by a 1.185 beta, 38.12% annualized 20-day realized volatility, an equal to 4.07% of price, a now-confirmed breakdown, and back-to-back misses of -14.4% in Q2 2026 and -29.9% in Q3 2026 that show earnings power is not yet immune to AI infrastructure and operating-cost pressure. It belongs as a sized-down Core Growth holding rather than a portfolio anchor, with additions staged only after a reclaim of the $644.49 or evidence that FY2026 estimate cuts have stopped. Expect 15-25% drawdowns around earnings and AI-spending sentiment shifts to remain normal rather than exceptional.
Analyst Spread
Mean Target
$845.50
High / Low
$629 / $1050
Median Target
$850.00
Consensus range
$629 - $1050
— analysts
Mean
$629$845$1050
Consensus
The $845.50 mean and $850.00 median targets imply roughly 34.1% and 34.8% upside from $630.56, and the October 22 cluster of target increases from UBS, Citigroup, DA Davidson, BMO and Evercore shows sell-side models are still willing to capitalize Muse and Enterprise Platform optionality after the miss. The $629.06 low target has now converged to the current price, implying essentially zero downside, which can be read either as a floor forming or as the most bearish analyst having been overrun by price; the $1,050 high target implies about 66.5% upside. The resulting $420.94 spread equals roughly 66.8% of the share price and reflects genuine disagreement about AI spending returns and the pace of new monetization. The number of price-target analysts is null in the bundle, although the separate recommendation panel contains 62 ratings and is overwhelmingly positive, so target statistics should be treated as directional rather than precisely weighted.
Positioning Pulse
Insider Signal
Neutral
Net Bias
No recent activity
Insider Own.
0.1%
Institutional Own.
78.8%
Interpretation
With two small, unclassifiable filings and no confirmable open-market buy or sell, insider activity provides no usable directional signal about management's confidence following the Q3 miss, and it should not be used to offset or reinforce the bearish technical picture.
Notable activity
Only two Form-4 rows are supplied: Officer Jennifer Newstead with 519 directly held shares valued at $325,932 and Chief Operating Officer Javier Olivan with 517 directly held shares valued at $326,227. The transaction-type field is blank and the dates are encoded as 149 and 148 rather than readable calendar dates, so neither filing can be classified as a discretionary open-market purchase or sale, and the bundle does not state whether either sits under a 10b5-1 plan.
Market Context
Industry
Internet Content & Information
Bearish
Sentiment
-36
Tracked names
4
Grouping
industry
Internet Content & Information industry is currently Bearish with an average recommendation score near 45. capital and conviction are fading across the group, and leadership is concentrated in GOOGL, NBIS, PINS.
Rotation Drivers
Average recommendation deltas are rolling over across Internet Content & Information industry, which points to capital rotating away from the group.
0 names are rated bullish versus 0 bearish names, keeping the group tone bearish.
Leadership is concentrated in GOOGL, NBIS, PINS, so those names are the cleanest read on group-level capital rotation.
Meta has converted an AI research narrative into shipping products, combining consumer distribution through Muse with an enterprise push via Muse API, Muse Code and Meta Business Agent under newly named Chief Enterprise Platform Officer CJ Desai. Muse reportedly topped both the Apple App Store and Google Play Store with millions of users, and the Enterprise Platform launch knocked Atlassian shares down 4.6% to $179.73 intraday, evidence that capital is being reallocated away from legacy collaboration software toward hyperscaler-backed agent suites. The Q3 2026 miss and the absence of disclosed paid-conversion or enterprise-revenue figures temper the theme, leaving product evidence strong but monetization unproven and the transaction take-rate model unquantified.
The post-earnings reset and the October 26 breakdown force the market to prove Muse and Enterprise Platform can produce measurable revenue before AI infrastructure costs further compress margins.
Post-print target increases from UBS to $892, Citigroup to $905, DA Davidson to $800 and Evercore to $870 show sell-side capital still willing to underwrite the agent monetization story despite the miss.
Meta's Enterprise Platform launch was cited as the direct cause of a 4.6% intraday drop in Atlassian shares to $179.73, confirming the offering is being priced as a real competitive threat inside enterprise software.
AI Infrastructure and Compute Buildout
Score: -30
Mixed-Bearish
The AI infrastructure trade remains the dominant capital-allocation narrative in mega-cap technology, but for Meta it is primarily a return-on-capital question rather than a revenue exposure. Nvidia's record $150 billion incremental buyback, funded from $74.4 billion of first-half FY2027 operating cash flow with $46.1 billion already returned and a stock trading near 18.7x forward earnings, contrasts with Meta's $16.85 billion of trailing free cash flow against $133.09 billion of operating cash flow and a 1.05% FCF yield. The Q3 miss and the subsequent 1.88% breakdown to $630.56 on 1.59x volume show capital favoring proven AI cash generators over AI capital spenders, making the theme a net drag on Meta sentiment until returns are demonstrated.
The Q3 miss and the confirmed break directly raise the question of whether Meta's AI infrastructure spending is converting into earnings and cash flow at the pace investors now require.
Nvidia rose more than 3% on its $150 billion buyback while Meta fell 6.99% post-earnings and a further 1.88% on October 26, a concrete signal that capital is rotating toward proven AI cash generators and away from AI capital spenders.
The 10-year Treasury yield at 4.986% and a 4.07% on Meta show that high-beta AI spenders carry disproportionate drawdown risk when discount rates stay near 5%.
Key Stats
23 metrics total
Market Cap
$1.61T
P/E (TTM)
21.5
Forward P/E
18.0
Revenue Growth
26.1%
ROE
32.3%
Beta
1.18
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
6.6
Price / Book
5.9
EV / EBITDA
14.4
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
81.0%
Operating Margin
35.4%
Debt / Equity
42.2
Current Ratio
1.90x
Quick Ratio
1.67x
Positioning & Range
Short interest and 52-week location.
Short % Float
1.5%
Short Ratio
1.44x
52W High
$779.82
52W Low
$520.26
From 52W High
-19.1%
From 52W Low
21.2%
Company Classification
Sector and industry context.
Sector
Communication Services
Industry
Internet Content & Information
Additional Signals
Free Cash Flow
$16848499712.00
Detailed Analysis
Valuation
At $630.56 Meta trades at 21.51x trailing earnings, 17.97x forward, 14.42x , 6.65x sales and 5.92x book, all lower than the prior run (21.92x trailing, 18.47x forward, 14.76x , 6.78x sales, 6.02x book), but again the improvement is entirely price-driven after the further 1.88% decline rather than estimate-driven. The of 0.85 is far more usable than the prior run's 0.08 artifact, which was computed off a low-base 264.8% earnings-growth figure; if the implied roughly 21% growth rate holds, a sub-1.0 would make Meta cheap relative to growth, but two consecutive misses (-14.4% in June 2026 and -29.9% in September 2026) and an 11.6% ninety-day cut to FY2026 argue the growth denominator is still too high. The honest anchor is a 17.97x forward multiple on FY2026 of $29.20173, which has fallen 4.1% in seven days, against 26.1% revenue growth, an 81.03% gross margin and a 1.05% free-cash-flow yield. The market is paying roughly 14.4x for a 48.09% -margin business, which is not demanding in absolute terms, but 6.65x sales already discounts Muse and Enterprise Platform monetization that has not appeared in reported revenue. Enterprise value of $1.675 trillion is only 1.04x market capitalization, so the valuation rests on operating earnings power rather than leverage. The stock is 19.14% below its 52-week high of $779.82 and 21.20% above its $520.26 low, at the 42.49 percentile of the annual range.
Balance Sheet
Debt-to-equity of 42.16% is conservative for a company of this scale, though leverage rose slightly from the prior run. Cash of $82.45 billion against total debt of $114.84 billion leaves net debt of $32.39 billion, equal to 2.02% of the $1.606 trillion market capitalization, with cash covering 0.72x gross debt and operating cash flow of $133.09 billion covering total debt 1.16x, so solvency and refinancing are not meaningful risks. Liquidity is strong at a 1.90 current ratio and a 1.67 quick ratio. The soft spot is cash conversion, and it got worse: trailing free cash flow fell to $16.85 billion from $18.65 billion in the prior run, only 12.7% of the $133.09 billion of operating cash flow and a 1.05% free-cash-flow yield, versus 14.0% and 1.14% previously, confirming that investment intensity is rising faster than operating cash generation. The 32.26% and 14.58% are generated by operating profitability rather than balance-sheet leverage.
Growth
Revenue growth remains strong at 26.1% year over year but has decelerated from 28.0% in the prior run, so the top line is slowing even before AI costs are fully annualized. Reported earnings growth of 264.8% is not comparable across periods because it laps the depressed September 2025 quarter when was $1.05 on a -84.3% surprise, and the more relevant signal is the sequential deterioration: missed by -14.4% in Q2 2026 and by -29.9% in Q3 2026. FY2026 is $29.20173 versus $30.46424 seven days ago and $33.04684 ninety days ago, while FY2027 is $33.97029, up from $33.82523 a week ago but below $35.09669 ninety days ago, so the near year is being cut hard while the out year is stabilizing. Profit margin stands at 31.15%. Gross margin is 81.03% and margin 48.09% while operating margin holds 35.41%, a mix consistent with depreciation and infrastructure costs building beneath a still-healthy operating line.
Business Quality
An 81.03% gross margin, a 35.41% operating margin and a 48.09% margin describe a software-like cost structure inside a scaled advertising platform, and of 14.58% with of 32.26% confirm capital is deployed profitably at the asset level. Liquidity is ample at a 1.90 current ratio and a 1.67 quick ratio. Institutional ownership of 78.8% against insider ownership of 0.147% reflects a professionally held base that offers no protection in a high-beta drawdown, and short interest of 1.52% of float with a 1.44 short ratio means there is little active bearish positioning and therefore no squeeze fuel either. These quality metrics comfortably justify a premium multiple relative to the broader market; the open question raised by two consecutive misses is whether future cash conversion can keep pace with the depreciation and operating costs the AI buildout is creating, since a 12.7% FCF conversion rate is thin for a franchise of this quality.
Capital Allocation
Meta holds $82.45 billion of cash against $114.84 billion of debt and generates $133.09 billion of operating cash flow, but trailing free cash flow is only $16.85 billion after investment, so roughly 87% of operating cash flow is being reinvested rather than converted. The prior analysis carried FY2026 capex guidance of $135-$145 billion as the largest discretionary commitment; this bundle does not update that figure and it should be treated as an unverified carry-forward. The dividend yield of 0.33% with a 7.16% payout ratio is immaterial as a capital-return lever, and the bundle contains no share-count history or company-specific buyback data, so net repurchases or dilution cannot be assessed; notably, the only large buyback discussed in the news flow is Nvidia's $150 billion authorization, which that article explicitly contrasts with Meta's less aggressive repurchase record. Capital deployment creates value only if advertising productivity plus Muse and Enterprise Platform revenue eventually exceed the infrastructure, depreciation and operating costs being committed today.
Estimate Revisions
Revision breadth and magnitude remain negative at the full-year level. FY2026 has fallen to $29.20173 from $30.46424 seven days ago, a 4.1% cut, and from $33.04684 ninety days ago, an 11.6% decline. Next-quarter is $7.60723 versus $7.86446 a week ago, a 3.3% one-week decline, and $8.33430 ninety days ago, an 8.7% ninety-day decline. Against that, the current-quarter estimate edged up to $8.33709 from $8.27679 and FY2027 rose to $33.97029 from $33.82523, which is the one constructive thread in an otherwise negative tape. Over the last seven days the current year shows one upward versus two downward revisions, and over thirty days four upward versus six downward; the out year is better behaved at seven upward versus three downward over thirty days. The rating panel stands at 9 Strong Buy, 46 Buy, 6 Hold and 1 Sell across 62 ratings, unchanged from a month ago, with zero upgrades and zero downgrades in 90 days. Post-print price-target actions were bullish despite the miss: UBS to $892 from $884, Citigroup to $905 from $895, DA Davidson to $800 from $700, BMO to $685 from $580 and Evercore to $870 from $860.